Depending on the nationality and regulatory environment of the clinic, re-purposing of excised tissues and samples collected during the course of standard care for use in research may or may not require the consent of the patient.
This extensive repository supports a wide range of cancer research studies, from molecular and genetic analysis to clinical trials.
The ability to access such a large and diverse collection of samples has been instrumental in advancing our understanding of cancer and improving therapeutic strategies.
This large-scale collection underscores the critical role that well-maintained and ethically governed tumor banks play in the advancement of translational cancer research.
Personalized medicine may influence clinical policies related to biobanking as treatments may increasingly use the genetic characteristics of each individual's own cancer to select or develop uniquely targeted therapies.